Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

BACKGROUND: The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the efficacy and safety of adjuvant transcatheter arterial chemoembolization (TACE) a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Commun (Lond)
Glavni autori: Wei, Wei, Jian, Pei-En, Li, Shao-Hua, Guo, Zhi-Xing, Zhang, Yong-Fa, Ling, Yi-Hong, Lin, Xiao-Jun, Xu, Li, Shi, Ming, Zheng, Lie, Chen, Min-Shan, Guo, Rong-Ping
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6235393/
https://ncbi.nlm.nih.gov/pubmed/30305149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-018-0331-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items